Kinnate biopharma inc.

Other-Pharmaceuticals

KNTE


Executive/
Director

Price

  • Last Close
  • $ 2.65
    $ -0.01 -0.38 %
    Apr 2, 2024
  • 52-Week High/Low
  • $2.66 - $1.07
  • YTD
  • 0%

  • Trading Volume
  • 2,812,224
  • Market Cap Full
  • $ 124.8M
  • Shares Outstanding
  • 47.1M
    Nov 3, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - - - -5% -25.2% -36.5% 2.5% 12.2% -
Q2 - - - - 4% -21.8% 12% -51.5% -0.4% -
Q3 - - - - 8% -1.1% -5.2% -53.8% - -
Q4 - - - - 1.9% -23% -49% 68.1% - -
J F M A M J J A S O N D
2025 - - - - - - - - - - - -
2024 - 4.2% 7.7% -0.4% - - - - - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%0%0%0%-55%-66%-61%12%0%

Earnings

2020 2021 2022 2023
Q1 - -0.4 -0.61 -0.73
Q2 - -0.49 -0.62 -0.68
Q3 - -0.57 -0.7 -0.65
Q4 - -0.6 -0.71 -
A -5.3 -2.1 -2.6 -2.06

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2021 2022 2023
Mar - 43.9 46.6
Jun 43.5 44 46.6
Sep 43.7 44.1 47.1
Dec 43.7 44.2 47.1

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 39.7 - - - -
Equity multiplier 0.2 0.3 - - -